Factors Influencing the Stability of Blood Eosinophils Counts in Chronic Obstructive Pulmonary Disease Patients.


Journal

Canadian respiratory journal
ISSN: 1916-7245
Titre abrégé: Can Respir J
Pays: Egypt
ID NLM: 9433332

Informations de publication

Date de publication:
2022
Historique:
received: 09 01 2022
revised: 02 03 2022
accepted: 07 03 2022
entrez: 7 4 2022
pubmed: 8 4 2022
medline: 9 4 2022
Statut: epublish

Résumé

Blood eosinophil (EOS) has recently been recognized as a biomarker for chronic obstructive pulmonary disease (COPD) patients. However, few studies have concentrated on the stability of blood eosinophil counts (BEC), and those studies have produced varying results. With further research, we have found minor drawbacks and vulnerabilities that lead to the variability of the results. This paper enumerates several areas of relevant research with varying conclusions to further investigate the stability of BEC in COPD patients.

Identifiants

pubmed: 35387448
doi: 10.1155/2022/8369521
pmc: PMC8977339
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8369521

Informations de copyright

Copyright © 2022 Cheng-Sen Cai and Jun Wang.

Déclaration de conflit d'intérêts

There are no conflicts of interest between all authors.

Références

Eur Respir J. 2017 Nov 22;50(5):
pubmed: 29167301
Eur Respir J. 2020 Nov 5;56(5):
pubmed: 32471933
COPD. 2017 Aug;14(4):382-388
pubmed: 28569614
Allergol Int. 2018 Apr;67(2):172-178
pubmed: 29433946
Eur Respir J. 2020 May 7;55(5):
pubmed: 32060064
Int J Chron Obstruct Pulmon Dis. 2019 May 16;14:1045-1051
pubmed: 31190789
Int J Chron Obstruct Pulmon Dis. 2018 Sep 28;13:2999-3002
pubmed: 30319247
Am J Respir Crit Care Med. 2017 May 15;195(10):1402-1404
pubmed: 28165763
Lancet Respir Med. 2019 Aug;7(8):699-709
pubmed: 31122894
Respir Res. 2020 Jan 10;21(1):15
pubmed: 31924207
Eur Respir J. 2020 May 14;55(5):
pubmed: 32060069
Chest. 2019 Sep;156(3):456-465
pubmed: 31047957
Int J Chron Obstruct Pulmon Dis. 2020 Aug 31;15:2061-2070
pubmed: 32943859
Arch Bronconeumol. 2017 Aug;53(8):443-449
pubmed: 28495077
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Respir Res. 2020 Feb 12;21(1):50
pubmed: 32050955
Int J Chron Obstruct Pulmon Dis. 2021 Jun 17;16:1783-1799
pubmed: 34168440
Respir Res. 2018 Jul 13;19(1):134
pubmed: 30001715
BMJ Open Respir Res. 2016 Sep 08;3(1):e000151
pubmed: 27651909
Chin Med J (Engl). 2019 Oct 5;132(19):2373-2375
pubmed: 31567377
Allergy. 2020 Feb;75(2):370-380
pubmed: 31506971
Int J Chron Obstruct Pulmon Dis. 2020 May 19;15:1123-1134
pubmed: 32547000
Diagnostics (Basel). 2021 Feb 27;11(3):
pubmed: 33673418
Respir Investig. 2021 Jul;59(4):487-497
pubmed: 33994346

Auteurs

Cheng-Sen Cai (CS)

Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, ShanDong 250001, China.

Jun Wang (J)

Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, ShanDong 250001, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH